Cubist Systematic Strategies’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-557,240
Closed -$8.92M 3060
2025
Q2
$8.92M Buy
557,240
+239,257
+75% +$4.27M 0.04% 671
2025
Q1
$6.18M Sell
317,983
-232,619
-42% -$4.9M 0.04% 754
2024
Q4
$12.1M Sell
550,602
-68,205
-11% -$1.31M 0.08% 382
2024
Q3
$10.4M Buy
618,807
+228,081
+58% +$3.38M 0.06% 435
2024
Q2
$4.67M Sell
390,726
-96,162
-20% -$1.07M 0.03% 824
2024
Q1
$5.39M Buy
486,888
+149,755
+44% +$1.53M 0.03% 915
2023
Q4
$2.92M Buy
337,133
+241,593
+253% +$1.88M 0.02% 1217
2023
Q3
$731K Buy
+95,540
New +$717K 0.01% 2086

Other funds holding CLBT

Cubist Systematic Strategies's CLBT Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 557,240 shares — an estimated $8.92M sold.

Cubist Systematic Strategies first reported a position in CLBT in Q3 2023 and held it in 8 quarters. The position peaked at $12.1M in Q4 2024. 196 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 557,240 Cellebrite shares in Q3 2025, an estimated $8.92M.
  • Cubist Systematic Strategies first reported a position in Cellebrite in Q3 2023 and held it in 8 quarters.
  • Cubist Systematic Strategies's Cellebrite position peaked at $12.1M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.